ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,130,045 | +5.2% | 10,423,135 | +24.7% | 0.38% | +27.7% |
| Q2 2023 | $7,730,449 | +18.3% | 8,357,242 | +39.5% | 0.30% | +4.2% |
| Q1 2023 | $6,531,902 | -7.6% | 5,992,571 | +23.7% | 0.29% | +13.8% |
| Q4 2022 | $7,071,525 | -29.4% | 4,843,510 | -48.0% | 0.25% | -30.3% |
| Q3 2022 | $10,020,000 | -35.3% | 9,320,584 | +2.3% | 0.36% | -38.6% |
| Q2 2022 | $15,487,000 | +216.6% | 9,109,780 | +283.6% | 0.59% | +223.0% |
| Q1 2022 | $4,892,000 | -59.2% | 2,374,674 | -25.8% | 0.18% | -55.3% |
| Q4 2021 | $12,004,000 | -47.3% | 3,201,066 | -27.3% | 0.41% | -38.9% |
| Q3 2021 | $22,766,000 | +47.3% | 4,403,574 | +21.4% | 0.67% | +38.2% |
| Q2 2021 | $15,455,000 | +16.4% | 3,627,900 | +45.0% | 0.48% | +19.2% |
| Q1 2021 | $13,282,000 | -8.6% | 2,501,303 | -7.2% | 0.41% | -20.5% |
| Q4 2020 | $14,525,000 | +114.3% | 2,694,769 | +217.2% | 0.51% | +63.3% |
| Q3 2020 | $6,779,000 | -43.5% | 849,440 | -15.3% | 0.31% | -7.4% |
| Q3 2015 | $12,005,000 | -32.2% | 1,002,953 | +3.9% | 0.34% | -24.6% |
| Q2 2015 | $17,698,000 | – | 965,515 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |